These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7844449)

  • 1. [Circumvention of cisplatin resistant ovarian cancer cells by antiestrogens].
    Ishii K; Kita T; Kudo K; Hisano A; Hirata J; Imaizumi E; Tode T; Kikuchi Y; Nagata I
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):19-26. PubMed ID: 7844449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antiproliferative effect of cis-diamminedichloroplatinum(II) by clomiphene and tamoxifen in human ovarian cancer cells.
    Kikuchi Y; Hirata J; Kita T; Imaizumi E; Tode T; Nagata I
    Gynecol Oncol; 1993 Jun; 49(3):365-72. PubMed ID: 8314539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
    Kudoh K; Kikuchi Y; Hiramatsu H; Hirata J; Yamamoto K; Kita T; Nagata I
    Eur J Cancer; 1997 Jan; 33(1):122-8. PubMed ID: 9071911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine].
    Kudoh K; Kita T; Hirata J; Ishii K; Hiramatsu H; Kikuchi Y; Nagata I
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jun; 46(6):525-32. PubMed ID: 8040625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytokinetic effects of cisplatin on cisplatin-resistant ovarian cancer cell lines].
    Sasa H; Kikuchi Y; Hisano A; Ishii K; Nagata I; Kawai T; Aida S; Sugita M; Sugishita T; Tenjin Y
    Hum Cell; 1992 Dec; 5(4):384-91. PubMed ID: 1304801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine.
    Hirata J; Kikuchi Y; Kita T; Imaizumi E; Tode T; Ishii K; Kudoh K; Nagata I
    Int J Cancer; 1993 Sep; 55(3):521-7. PubMed ID: 8375936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice.
    Hiramatsu H; Kikuchi Y; Kudoh K; Kita T; Tode T; Nagata I
    Jpn J Cancer Res; 1997 Oct; 88(10):1003-8. PubMed ID: 9414663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells.
    Futagami M; Sato S; Sakamoto T; Yokoyama Y; Saito Y
    Gynecol Oncol; 2001 Sep; 82(3):544-9. PubMed ID: 11520153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toremifene sensitized the effect of adriamycin on human breast cancer cell lines].
    Nakagomi H; Furuya K; Hagiwara J; Nishio T; Watanabe K; Muto S; Takano K; Tada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():454-8. PubMed ID: 9589052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines.
    Kuppen PJ; Schuitemaker H; van 't Veer LJ; de Bruijn EA; van Oosterom AT; Schrier PI
    Cancer Res; 1988 Jun; 48(12):3355-9. PubMed ID: 2897238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined effects of toremifene and paclitaxel on human breast cancer cell lines].
    Maruyama S; Kuroiwa S; Saimoto A; Nishikawa K
    Gan To Kagaku Ryoho; 2003 May; 30(5):669-75. PubMed ID: 12795099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
    Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].
    Yoshiya N; Adachi S; Misawa Y; Yuzawa H; Honda T; Kanazawa K; Takeuchi S Tanaka K; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):7-14. PubMed ID: 2647872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of resistance to cisplatin is associated with decreased expression of the gp185c-erbB-2 protein and alterations in growth properties and responses to therapy in an ovarian tumor cell line.
    Langton-Webster BC; Xuan JA; Brink JR; Salomon DS
    Cell Growth Differ; 1994 Dec; 5(12):1367-72. PubMed ID: 7696185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A; Weixel K; Saijo N
    Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L; Davis R; Anwar A; Behbakht K
    Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD; Li M; Yuan Y; Mao N; Pan LY
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK; Boldt DH; Estrada P
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.